Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity

Antimicrob Agents Chemother. 2005 Jan;49(1):418-20. doi: 10.1128/AAC.49.1.418-420.2005.

Abstract

A survey of emm gene sequences and an analysis of the pulsed-field electrophoretic profiles of 30 Streptococcus pyogenes isolates with reduced susceptibilities to ciprofloxacin detected the prevalence of isolates with emm type 6 and considerable genetic diversity among isolates. The mechanism of ciprofloxacin resistance in these isolates was based on point mutations in topoisomerase IV subunit C encoded by parC, mainly replacement of serine-79 by alanine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Infective Agents / pharmacology*
  • Antigens, Bacterial / genetics
  • Bacterial Outer Membrane Proteins / genetics
  • Carrier Proteins / genetics
  • Child
  • Child, Preschool
  • Ciprofloxacin / pharmacology*
  • DNA Topoisomerase IV / genetics*
  • Drug Resistance, Bacterial / genetics*
  • Genetic Variation
  • Humans
  • Infant
  • Microbial Sensitivity Tests
  • Pharyngitis / microbiology
  • Pharynx / microbiology*
  • Point Mutation
  • Spain
  • Streptococcal Infections / microbiology
  • Streptococcus pyogenes / classification
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / genetics
  • Streptococcus pyogenes / isolation & purification

Substances

  • Anti-Infective Agents
  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • Carrier Proteins
  • streptococcal M protein
  • Ciprofloxacin
  • DNA Topoisomerase IV